Revelation Biosciences Inc (REVB)
2.37
+0.02
(+0.85%)
USD |
NASDAQ |
May 03, 16:00
2.30
-0.07
(-2.95%)
After-Hours: 20:00
Revelation Biosciences Price to Book Value: 0.5822 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.5822 |
| May 02, 2024 | 0.5772 |
| May 01, 2024 | 0.5281 |
| April 30, 2024 | 0.5176 |
| April 29, 2024 | 0.5207 |
| April 26, 2024 | 0.5355 |
| April 25, 2024 | 0.5256 |
| April 24, 2024 | 0.5134 |
| April 23, 2024 | 0.5085 |
| April 22, 2024 | 0.5035 |
| April 19, 2024 | 0.5502 |
| April 18, 2024 | 0.5502 |
| April 17, 2024 | 0.5281 |
| April 16, 2024 | 0.4692 |
| April 15, 2024 | 0.4483 |
| April 12, 2024 | 0.5109 |
| April 11, 2024 | 0.5699 |
| April 10, 2024 | 0.5674 |
| April 09, 2024 | 0.5969 |
| April 08, 2024 | 0.6386 |
| April 05, 2024 | 0.6558 |
| April 04, 2024 | 0.6681 |
| April 03, 2024 | 0.6386 |
| April 02, 2024 | 0.6362 |
| April 01, 2024 | 0.6534 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.673 |
| March 27, 2024 | 0.5969 |
| March 26, 2024 | 0.6386 |
| March 25, 2024 | 0.5871 |
| March 22, 2024 | 0.5822 |
| March 21, 2024 | 0.6018 |
| March 20, 2024 | 0.5969 |
| March 19, 2024 | 0.56 |
| March 18, 2024 | 0.5871 |
| March 15, 2024 | 0.1437 |
| March 14, 2024 | 0.1407 |
| March 13, 2024 | 0.155 |
| March 12, 2024 | 0.186 |
| March 11, 2024 | 0.2004 |
| March 08, 2024 | 0.2027 |
| March 07, 2024 | 0.2027 |
| March 06, 2024 | 0.1789 |
| March 05, 2024 | 0.1902 |
| March 04, 2024 | 0.2033 |
| March 01, 2024 | 0.2171 |
| February 29, 2024 | 0.2176 |
| February 28, 2024 | 0.2457 |
| February 27, 2024 | 0.2045 |
| February 26, 2024 | 0.1884 |
| February 23, 2024 | 0.167 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1227
Minimum
Feb 02 2024
9.701
Maximum
Feb 13 2023
1.640
Average
0.561
Median
Jan 09 2024
Price to Book Value Benchmarks
| Cardiff Oncology Inc | 2.255 |
| Ocular Therapeutix Inc | 10.06 |
| Ocugen Inc | 8.437 |
| Cue Biopharma Inc | 2.794 |
| Solid Biosciences Inc | 3.023 |
Price to Book Value Related Metrics
| PE Ratio | 0.078 |
| Price | 2.37 |
| Earnings Yield | 1.28K% |
| Market Cap | 3.87M |